-
-
-
-
-
-
-
Redhill Biopharma (RDHL) Begins Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease
-
-
-
-
-
-
-
Pre-Open Movers 11/08: (MBI) (OPHT) (TTWO) Higher; (RDHL) (LC) (SNAP) Lower (more...)
-
-
-
-
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

